NO971505D0 - Trofinin og trofininhjelperproteiner - Google Patents

Trofinin og trofininhjelperproteiner

Info

Publication number
NO971505D0
NO971505D0 NO971505A NO971505A NO971505D0 NO 971505 D0 NO971505 D0 NO 971505D0 NO 971505 A NO971505 A NO 971505A NO 971505 A NO971505 A NO 971505A NO 971505 D0 NO971505 D0 NO 971505D0
Authority
NO
Norway
Prior art keywords
trophine
helper proteins
helper
proteins
trophine helper
Prior art date
Application number
NO971505A
Other languages
English (en)
Inventor
Michiko N Fukuda
Original Assignee
Jolla Cancer Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/317,522 external-priority patent/US5599918A/en
Application filed by Jolla Cancer Res Found filed Critical Jolla Cancer Res Found
Publication of NO971505D0 publication Critical patent/NO971505D0/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/471—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
NO971505A 1994-10-04 1997-04-03 Trofinin og trofininhjelperproteiner NO971505D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/317,522 US5599918A (en) 1994-10-04 1994-10-04 Nucleic acids encoding trophinin and trophinin-assisting proteins
US08/439,818 US5654145A (en) 1994-10-04 1995-05-12 Trophinin and trophinin-assisting nucleic acids and methods of detection thereof
PCT/US1995/013259 WO1996010414A1 (en) 1994-10-04 1995-10-04 Trophinin and trophinin-assisting proteins

Publications (1)

Publication Number Publication Date
NO971505D0 true NO971505D0 (no) 1997-04-03

Family

ID=26981004

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971505A NO971505D0 (no) 1994-10-04 1997-04-03 Trofinin og trofininhjelperproteiner

Country Status (8)

Country Link
US (5) US5654145A (no)
EP (1) EP0790830A1 (no)
JP (1) JPH10509581A (no)
AU (1) AU4130896A (no)
CA (1) CA2201119A1 (no)
FI (1) FI971376A0 (no)
NO (1) NO971505D0 (no)
WO (1) WO1996010414A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654145A (en) * 1994-10-04 1997-08-05 La Jolla Cancer Research Foundation Trophinin and trophinin-assisting nucleic acids and methods of detection thereof
US6733991B1 (en) * 1998-05-08 2004-05-11 Osi Pharmaceuticals, Inc. AGS proteins and nucleic acid molecules and uses therefor
US6746852B1 (en) * 1998-05-08 2004-06-08 Osi Pharmaceuticals, Inc. AGS proteins and nucleic acid molecules and uses thereof
US7172762B1 (en) * 1999-01-29 2007-02-06 Pfizer Inc. Erysipelothrix rhusiopathiae antigens and vaccine compositions
US6737052B1 (en) * 1999-08-31 2004-05-18 Board Of Regents, University Of Texas System Induction of programmed cell death by N5 gene
US7247297B2 (en) * 2001-09-14 2007-07-24 The University Of Chicago Use of DF3/MUC1 regulated expression in gene therapy
ES2330465T3 (es) * 2006-02-03 2009-12-10 Mtm Laboratories Ag Procedimiento para realizar un inmunoensayo desnaturalizante.
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US10194906B2 (en) 2015-09-25 2019-02-05 Ethicon Llc Hybrid robotic surgery with manual and robotic modes
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3678076A (en) * 1970-12-21 1972-07-18 Bristol Myers Co Tetrahydrodibenzothiophenes
US4732763A (en) * 1978-10-17 1988-03-22 Stolle Research And Development Corporation Active/passive immunization of the internal female reproductive organs
US5344919A (en) * 1987-02-19 1994-09-06 The Scripps Research Institute Integrin from human epithelial cells
US4876332A (en) * 1987-10-08 1989-10-24 Regents Of The Univeristy Of Minnesota Polypeptides with type IV collagen activity
US5240922A (en) * 1989-05-05 1993-08-31 Northern Sydney Area Health Service Fertility enhancement
US5227292A (en) * 1990-07-12 1993-07-13 University Of Utah Neurofibromatosis type 1 gene
US5279966A (en) * 1992-04-02 1994-01-18 The Trustees Of Columbia University In The City Of New York Cloning, expression and uses of a novel secreted protein, F-spondin
US5478725A (en) * 1992-06-12 1995-12-26 University Of Pennsylvania αv β3 integrin as a predictor of endometriosis
US5279941A (en) * 1992-06-12 1994-01-18 Trustees Of The University Of Pennsylvania Determination of endometrial receptivity toward embryo implantation
US5395825A (en) * 1993-03-10 1995-03-07 Yale University Fertility regulation with transforming growth factor β
US5521067A (en) * 1993-11-24 1996-05-28 University Of Rochester Bone marrow cell adhesion molecules and process for detecting adherence between cell adhesion molecules and cells generally
US5599918A (en) * 1994-10-04 1997-02-04 La Jolla Cancer Research Foundation Nucleic acids encoding trophinin and trophinin-assisting proteins
US5654145A (en) * 1994-10-04 1997-08-05 La Jolla Cancer Research Foundation Trophinin and trophinin-assisting nucleic acids and methods of detection thereof

Also Published As

Publication number Publication date
US5858360A (en) 1999-01-12
EP0790830A1 (en) 1997-08-27
CA2201119A1 (en) 1996-04-11
US5910451A (en) 1999-06-08
US5654145A (en) 1997-08-05
JPH10509581A (ja) 1998-09-22
WO1996010414A1 (en) 1996-04-11
US6111089A (en) 2000-08-29
US5880267A (en) 1999-03-09
AU4130896A (en) 1996-04-26
FI971376A0 (fi) 1997-04-03

Similar Documents

Publication Publication Date Title
IS4481A (is) Díhýdrópyramídín og notkun þeirra
IS5525A (is) Innúðabúnaður og aðferð
IS4496A (is) Úðablöndur úr peptíðum og próteinum
DK0815861T3 (da) Sulfonamider og anvendelse deraf
NO983235D0 (no) Fikstur og protese innbefattende samme
NO20000700L (no) Interleukin-18-proteiner samt fremstilling og anvendelse derav
NO961425D0 (no) 1N-alkyl-N-arylpyrimidinaminer og derivater derav
DE69635673D1 (de) Blutsammelsystem und kupplung
DK0799577T3 (da) Peptidblanding og produkter deraf
NO994009D0 (no) Gensekvensator og metoder
BR9506832A (pt) N-pirazolilanilinas e n-pirazolilaminopiridinas
DK0804078T3 (da) Sammensætning og anvendelse deraf
NO972206D0 (no) Bjelke og karosserikonstruksjon
NO964541L (no) Porphacyanin og CNC-utvidete porphyriner
NO971505D0 (no) Trofinin og trofininhjelperproteiner
NO985806D0 (no) Kitinasematerialer og fremgangsmÕter
DE69510034D1 (de) Trennbare und wiederanschliessbare verbindungsvorrichtung
NO960766D0 (no) Nytt protein og fremgangsmåte for fremstilling av dette
NO983556L (no) Formulering og anvendelse
KR960010685A (ko) 펩티드 및 그 용도
NO983388D0 (no) Trifenylboran-kolofoniumaminaddukt og anvendelse derav
BR9507133A (pt) N-aril e n-alquilsulfonilaminais
NO985572D0 (no) Substituerte amidinobenzenderivater og medisinske preparater derav
NO954530D0 (no) Aryloksycykloalkenyl- og aryloksyimino-cykloalkenylhydroksyurinstoffer
DK1042286T3 (da) Gamme-glutamyl- og beta-aspartyl-holdige immunmodulerende forbindelser og tilhørense fremgangsmåder